Position in ZTS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$649,111,558
+$46,483,459 QoQ
Shares Held
5,491,173
+14.6% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.66350959986146.ToString("F0")%
Shared 0.ToString("F0")%
None 1.3364904001385496.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$20,450,330
PutShares
173,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $924,834,595 across 59 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (70.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
5,491,173 | $649,111,558 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
77,138 | $45,741,289 | |
| 3 | HLN |
Haleon plc
|
4,022,749 | $40,267,716 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
231,311 | $30,472,908 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,136,022 | $21,039,125 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
805,422 | $19,273,746 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
300,133 | $17,788,881 | |
| 8 | VTRS |
Viatris Inc
|
1,160,097 | $15,672,908 |
All Filings in ZTS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,450,330 | 173,000 | Put | Defined | 2026-05-11 | |
| 2026-03-31 | $649,111,558 | 5,491,173 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $602,628,099 | 4,789,605 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $863,453,047 | 5,901,128 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,132,675 | 26,500 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $947,724,367 | 6,077,104 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,044,438,009 | 6,343,383 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $987,900 | 6,000 | Call | Defined | 2025-05-13 | |
| 2024-12-31 | $966,614,483 | 5,932,698 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,225,703,337 | 6,273,433 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,128,528,004 | 6,509,737 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,026,242,065 | 6,064,902 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $512,366,991 | 2,595,972 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $446,441,203 | 2,566,049 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $445,700,143 | 2,588,120 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $409,711,198 | 2,461,615 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $332,929,357 | 2,271,780 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $309,690,020 | 2,088,408 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $371,377,796 | 2,160,555 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $451,104,827 | 2,391,987 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $591,315,924 | 2,423,128 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $637,300,463 | 3,282,685 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $668,820,505 | 3,588,863 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $611,539,719 | 3,883,285 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $148,950 | 900 | Put | Defined | 2021-02-09 | |
| 2020-12-31 | $688,984,443 | 4,163,048 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $655,508,982 | 3,963,893 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $543,890,103 | 3,968,842 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $495,706,981 | 4,211,972 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||